This is the first in a four-part blog series that examines the Clinical, Medical Affairs, Regulatory, and Safety business units at ArisGlobal.<\/p>\n
In November 2019, Sondra Pepe<\/a> joined ArisGlobal as Senior Director of Clinical Product Management. In this role, Sondra oversees strategy for the company\u2019s Clinical product platform that spans clinical operations and clinical data management. ArisGlobal Marketing sat down with Sondra and asked her to describe what attracted her to ArisGlobal and to articulate the vision for Clinical product strategy.<\/p> I wasn\u2019t looking for something new<\/span>,\u00a0<\/span>but\u00a0<\/span>when\u00a0<\/span>Sankesh<\/span>\u00a0(<\/span>Sankesh<\/span>\u00a0<\/span>Abbhi<\/span>, President and CEO)<\/span>\u00a0<\/span>talked\u00a0<\/span>to me\u00a0<\/span>about\u00a0<\/span>ArisGlobal\u2019s<\/span>\u00a0<\/span>vision<\/span>\u00a0and the opportunity at hand to truly transform clinical<\/span>,<\/span>\u00a0I just couldn\u2019t resist the chance to be a part of something so exciting<\/span>.\u00a0<\/span>ArisGlobal<\/span>\u00a0ha<\/span>s<\/span>\u00a0<\/span>been delivering comprehensive,\u00a0<\/span>platform\u00a0<\/span>clinical\u00a0<\/span>technologies<\/span>\u00a0for some time now<\/span>.\u00a0<\/span>Just as I saw in my work elsewhere, it hadn\u2019t been enough to truly empower life sciences companies to radically improve the day to day operations of clinical trials. Sure<\/span>,<\/span>\u00a0there have been isolated big wins\u00a0<\/span>but<\/span>,<\/span>\u00a0<\/span>by and large,\u00a0<\/span>most<\/span>\u00a0of our industry still functions the same way it did\u00a0<\/span>when I started\u00a0<\/span>almost 2 decades ago.\u00a0<\/span>Lately<\/span>,<\/span>\u00a0though<\/span>,<\/span>\u00a0there has been this seismic friction building. Clinical visionaries, medical futurists<\/span>,<\/span>\u00a0and even health authorities have been successfully experimenting with real-world evidence, adaptive trials, virtual trials<\/span>,<\/span>\u00a0and decentralized trials. There\u2019s so much of this churn right now<\/span>\u00a0<\/span>and it\u2019s\u00a0<\/span>really exciting<\/span>. However, many technology companies are looking to simply wait it out. They want to see where things land on the other side of the churn.\u00a0<\/span>\u00a0<\/span><\/p>\n Sankesh and the\u00a0<\/span>ArisGlobal<\/span>\u00a0leadership team<\/span>\u00a0and our board<\/span>\u00a0<\/span>have a nearly opposite position. They\u00a0<\/span>see\u00a0<\/span>a\u00a0<\/span>real opportunity\u00a0<\/span>here<\/span>\u00a0to leverage not just state<\/span>–<\/span>of<\/span>–<\/span>the<\/span>–<\/span>art platform SaaS technologies or big data<\/span>,<\/span>\u00a0but also AI, machine learning,\u00a0<\/span>automation,\u00a0<\/span>structured component authoring<\/span>,<\/span>\u00a0and deep<\/span>\u00a0knowledge of<\/span>\u00a0industry best practices\u00a0<\/span>to deliver world<\/span>–<\/span>class life sciences solutions.<\/span>\u00a0Our vision is to\u00a0<\/span>digitally transform drug development through simple, intelligent and unified technology.<\/span>\u00a0<\/span>In fact, with<\/span>\u00a0<\/span>LifeSphere<\/span>\u00a0<\/span>MultiVigilance<\/span><\/a>\u00a0<\/span>we\u2019re already delivering on that promise\u00a0<\/span>–<\/span>\u00a0simple, intelligent<\/span>,<\/span>\u00a0and unified<\/span>.\u00a0<\/span>That\u2019s\u00a0<\/span>precisely<\/span>\u00a0<\/span>what drew me in<\/span>.\u00a0<\/span>I am\u00a0<\/span>excited<\/span>\u00a0to sidle up next to our customers and deliver technologies that make th<\/span>e<\/span>\u00a0change<\/span>s coming to clinical trials<\/span>\u00a0easy<\/span>\u00a0and intuitive\u00a0<\/span>to adopt.\u00a0<\/span><\/p> For me<\/span><\/span>,<\/span><\/span>\u00a0<\/span>the\u00a0<\/span><\/span><\/span>real\u00a0<\/span><\/span><\/span>challenge and fun<\/span><\/span>\u00a0<\/span>of\u00a0<\/span><\/span><\/span>Product\u00a0<\/span><\/span><\/span>Management is\u00a0<\/span><\/span><\/span>in\u00a0<\/span><\/span><\/span>distill<\/span><\/span>ing<\/span><\/span>\u00a0<\/span>common need<\/span><\/span>s<\/span><\/span>\u00a0<\/span>and\u00a0<\/span><\/span><\/span>deliver<\/span><\/span>ing<\/span><\/span>\u00a0<\/span><\/span><\/span>innovation<\/span><\/span>s upon them<\/span><\/span>\u00a0<\/span>that users don\u2019t even know to ask for<\/span><\/span>.\u00a0<\/span><\/span><\/span>We see and hear these little<\/span><\/span>\u00a0<\/span>gems<\/span><\/span>,<\/span><\/span>\u00a0<\/span><\/span><\/span>those<\/span><\/span>\u00a0<\/span>spot<\/span><\/span>s<\/span><\/span>\u00a0<\/span>where we\u00a0<\/span><\/span><\/span>see\u00a0<\/span><\/span><\/span>our customer\u2019s<\/span><\/span>\u00a0<\/span>pain crystal clear and\u00a0<\/span><\/span><\/span>can<\/span><\/span>\u00a0<\/span><\/span><\/span>identify<\/span><\/span>\u00a0<\/span>innovative ways to eliminate that pain<\/span><\/span>.<\/span><\/span>\u00a0<\/span><\/span><\/span>That\u2019s the magic\u00a0<\/span><\/span><\/span>of great<\/span><\/span>\u00a0<\/span>Product Management\u00a0<\/span><\/span><\/span>\u2013 delighting users<\/span><\/span>.<\/span><\/span>You\u2019ve got deep experience in the eClinical world. Given your exposure to the industry, what attracted you most to ArisGlobal?<\/h3>
W<\/span><\/span>hat are your\u00a0<\/span><\/span><\/span>plans<\/span><\/span>\u00a0<\/span>for yourself<\/span><\/span>\u00a0<\/span>and\u00a0<\/span><\/span><\/span>your department<\/span><\/span>\u00a0<\/span>for 2020?<\/span><\/span>\u00a0<\/span><\/h3>